DJI zvoláva v rámci akcie Venice Production Bridge počas 83. ročníka Medzinárodného filmového festivalu v Benátkach stretnutie „filmári a vizionári"

Nová generácia, nový filmový jazyk: Osmo Pocket 4P otvára novú diskusiu o rozprávaní príbehov, kreatívnej slobode a profesionálnych nástrojoch.

BENÁTKY, Taliansko, 9. september 2026 /PRNewswire/ -- Spoločnosť DJI, svetový líder v oblasti civilných dronov a technológií pre kreatívne natáčanie, usporiadala počas podujatia Venice Production Bridge na 83. ročníku Medzinárodného filmového festivalu v Benátkach odborné fórum „Filmári a vizionári". Stretnutie spojilo začínajúcich režisérov a kameramanov, aby spoločne preskúmali otázku, na ktorú filmový priemysel ešte len začína hľadať odpovede: Keď sa filmová kamera zmestí do dlane, ako sa zmení samotný jazyk filmu?

Z Cannes do Benátok: jednotná vízia

Podujatie Venice Production Bridge pokračovalo v kreatívnej ceste, ktorú tento rok začala séria Osmo Pocket. Po celosvetovom predstavení na festivale v Cannes v máji zverila spoločnosť DJI kameru Osmo Pocket 4P dvom najvýraznejším vizuálnym tvorcom kinematografie, pričom každý z nich pracuje nezávisle na inom kontinente. Výsledky odhalili pozoruhodnú zhodu.

Vo filme „FAMILIARITÉ" si herečka Isabelle Huppertová, ocenená na festivaloch v Cannes i Benátkach, zahrala hlavnú úlohu a kreatívne režírovala originálnu meditáciu o literatúre a pamäti, ktorá bola celá natočená kamerou Osmo Pocket 4P. Uznávaný japonský kameraman Mikiya Takimoto zároveň navrhol a režíroval film „Hľadám ju" – príbeh v štýle road movie, ktorý sa odohráva v historickom mestečku, kde sa kedysi ťažilo striebro, a sleduje tiché hľadanie ľudského spojenia – taktiež kompletne cez kameru Osmo Pocket 4P. Z týchto dvoch nezávislých tvorivých procesov vzišlo jednotné presvedčenie: kamera, ktorá je dostatočne ľahká na to, aby sa zmestila do dlane, nerobí žiadne kompromisy v oblasti emocionálnej hĺbky alebo technickej presnosti. Oba filmy demonštrujú plný potenciál filmového rozprávania príbehov zhusteného do vreckovej formy. V Benátkach sa táto súkromná kreatívna pravda stala verejnou otázkou celého odvetvia.

Premietanie budúcnosti: od teórie k praxi

Stretnutie má formu skutočného dialógu so zúčastnenými odborníkmi, zamerané výlučne na filmovú prax, a nie na demonštráciu produktov. Premietali sa štyri krátke filmy vytvorené medzinárodnou skupinou začínajúcich kameramanov: Gabriele Mencaroni a Alessandro Tempestini (Taliansko), Liu Yadi (Čína/Francúzsko) a Zhou Chengzhou (Čína/Holandsko). Ich kolektívna tvorba zahŕňala experimentálny film, komerčnú produkciu aj dokumentárne filmy ocenené na festivaloch – táto rozmanitosť odráža generáciu, ktorá prekračuje tradičné tvorivé hranice.

Po premietaní a ukážke natáčania naživo poskytli dôkladnú profesionálnu kritiku traja medzinárodne uznávaní kameramani: Valentin Vignet, francúzsky kameraman známy svojou prácou na filme Faces Places a krátkometrážnom filme Nefta Football Club nominovanom na Oscara; Cristiano Di Nicola, oceňovaný taliansky kameraman zastúpený v Benátkach filmom „L'Estranea" v oficiálnej súťaži; a Michele D'Attanasio, dvojnásobný držiteľ ceny Davida di Donatella, známy filmami ako Veloce come il vento, Freaks Out a L'ombra di Caravaggio. Všetci traja majú skúsenosti s riadením rozsiahlych produkcií a hodnotili vizuálne rozprávanie mladých režisérov v porovnaní s nekompromisnými štandardmi profesionálnej kinematografie, pričom preukázali, že technická sofistikovanosť diel spĺňala tradičné kinematografické štandardy bez kompromisov.

Okrúhly stôl: odborná diskusia o novom poňatí kinematografie

Ústredným bodom bola diskusia za okrúhlym stolom na tému: „Ako nová generácia transformuje kinematografiu?" Debaty prepojili odlišné perspektívy skúsených kameramanov so začínajúcimi režisérmi a organicky preskúmali štyri základné dimenzie: ako kompaktné nástroje stabilizované pomocou gimbalu menia vzťah medzi kamerou, hercom a prostredím; či ľahšie a flexibilnejšie vybavenie demokratizuje profesionálnu filmovú tvorbu a zároveň vyžaduje väčšiu vizuálnu disciplínu; ako sa produkčné pracovné postupy a dynamika pri natáčaní transformujú vďaka ľahkej aparatúre; a nakoniec, či nástroj dokáže skutočne zmeniť samotný filmový jazyk, alebo či musí byť vždy na prvom mieste vizuálna myšlienka.

Valentin Vignet sa zamyslel nad mentálnym posunom, ktorý zažíva, keď z natáčania zmizne masívna kamerová zostava: protagonista sa už neprispôsobuje aparátu a kamera sa stáva skôr svedkom než prekážkou. „Na týchto štyroch krátkych filmoch ma najviac zaujalo to, že žiadny z filmárov nemusel kvôli použitiu ľahšej kamery robiť kompromisy v kvalite," povedal Cristiano Di Nicola. „Bolo tam toľko záberov, ktoré som predtým považoval za nemožné, a to preto, že Osmo Pocket 4P vás ako filmára oslobodzuje. Môžeme sa viac zamerať na rozprávanie príbehu, konkrétne na to, ako sa priblížiť k akcii, než na samotné nastavenie."

Medzikultúrni kameramani ako Liu Yadi a Zhou Chengzhou videli dôraz niekde inde: Ako si mladí kameramani udržiavajú skutočne filmový výraz v rámci prísnych limitov obmedzených rozpočtov a malých štábov? Odpoveď organicky vyplynula z dialógu: profesionálne štandardy – veda o farbách, dynamický rozsah, presnosť stabilizácie – sú teraz oddelené od rozsahu vybavenia. Kameraman, ktorý pracuje sám v obmedzenom priestore, môže využiť rovnako vyspelú techniku ako hollywoodsky štáb. Bariéra pre vstup do odvetvia sa neznížila obetovaním kvality, ale prerozdelením oblastí, v ktorých táto kvalita môže spočívať.

Akcia Venice Production Bridge, ktorú organizuje DJI, stelesňuje moment, keď sa základná otázka filmu posúva z „Aké vybavenie potrebujeme?" na „Čo bude možné, keď vybavenie prestane byť prekážkou?". Odpoveďou spoločnosti DJI je kamera Osmo Pocket 4P: profesionálna obrazová sila nezávislá od kritérií rozsahu priemyslu, ktorá umožňuje každému rozprávačovi v akomkoľvek prostredí – od úzkych uličiek Tokia až po kanoe na tichom záhradnom jazere – preniesť do svojej vízie plnú technickú a emocionálnu váhu kinematografie. Ide o novú éru definovanú dostupnosťou, ktorá sprístupňuje nástroje filmovej kvality väčšiemu počtu vizionárov a umožňuje im pri rozprávaní ich príbehov väčšiu kreatívnu slobodu. S menšími filmovými kamerami sa prejavuje skutočná sila zobrazovacej technológie: už nie ako obmedzenie predstavivosti, ale ako oslobodenie.

Share this article

Hylenr Technologies détecte des traces de terres rares et ouvre une nouvelle voie technologique grâce à la fusion nucléaire

HYDERABAD, Inde, 9 septembre 2026 /PRNewswire/ -- La société indienne deeptech Hylenr Technologies a annoncé avoir mis en évidence la formation d'éléments, notamment des terres rares, au sein de structures alvéolaires de conception avancée, ouvrant ainsi une voie radicalement différente vers la nucléosynthèse et la production de matériaux stratégiques.

Ces résultats s'inscrivent dans le cadre des travaux menés depuis plus de dix ans par Hylenr Technologies sur la technologie de fusion nucléaire basée sur la fusion par confinement dans une structure cristalline et ont également fait l'objet d'une collaboration et d'une validation avec des institutions de recherche internationales de premier plan.

Une partie de ces travaux, intitulée « Nuclear Signatures in a Hydrogen-Loaded Ni–Pd Lattice Confinement System » (Signatures nucléaires dans un système de confinement par réseau Ni-Pd chargé en hydrogène), a été présentée au début du mois lors de la 27e Conférence internationale sur la science nucléaire de la matière condensée (ICCF-27), aux Chutes du Niagara, au Canada.

De l'énergie nucléaire à la nucléosynthèse

La nucléosynthèse est le processus par lequel les noyaux atomiques se transforment pour donner naissance à différents éléments.

Dans la nature, ce phénomène se produit au sein des étoiles, des supernovae et d'autres environnements astrophysiques extrêmes, où des températures, des pressions et des densités d'énergie colossales déclenchent des réactions nucléaires.

Sur Terre, la production ou la transformation d'éléments par des processus nucléaires nécessite généralement des réacteurs nucléaires à grande échelle, des accélérateurs de particules ou des infrastructures expérimentales à haute énergie.

Les résultats d'Hylenr Technologies mettent en évidence une voie fondamentalement différente pour les processus nucléaires et la nucléosynthèse au sein de matériaux solides artificiels. Dans les réseaux métalliques chargés en hydrogène, les interactions entre l'hydrogène, les défauts du réseau, les lacunes et l'environnement électronique local créent des conditions extrêmes susceptibles de permettre des processus nucléaires au sein même du matériau.

Cela fait évoluer la conception de la formation des éléments, qui passe de systèmes gigantesques à haute énergie à une énergie nucléaire compacte et maîtrisée.

Détection des signatures de 32 éléments

Au cours d'environ deux ans de travaux d'analyse des matériaux, Hylenr Technologies a détecté des signatures correspondant à 32 éléments dans des échantillons post-opérationnels, parmi lesquels figurent des éléments légers, des éléments lourds et des gaz nobles tels que l'hélium, le néon et l'argon. Par ailleurs, les terres rares d'importance stratégique, notamment l'yttrium, et les actinides, notamment l'uranium. Les signatures sont comparées à la caractérisation de référence pré-opérationnelle du même échantillon de matériau catalytique servant de témoin, et chacune d'entre elles est corroborée par au moins une des techniques indépendantes ci-dessous.

Ces observations ont été analysées à l'aide de plusieurs techniques d'analyse indépendantes, notamment :

- Spectroscopie des rayons X à dispersion d'énergie (EDS)

- Spectroscopie photoélectronique à rayons X (XPS)

- Spectroscopie d'émission optique à plasma à couplage inductif (ICP-OES)

- Spectroscopie à rayons X à dispersion de longueur d'onde (WDX)

- Analyse des gaz résiduels (RGA)

Fabriqués, pas extraits

Les éléments de terres rares sont au cœur de nombreuses technologies parmi les plus importantes sur le plan stratégique à l'échelle mondiale.

Ils jouent un rôle essentiel dans les aimants permanents, les véhicules électriques, la robotique, les éoliennes, l'électronique, les systèmes aérospatiaux, les plateformes de défense et la fabrication de pointe.

« Pourtant, leur chaîne d'approvisionnement mondiale reste très concentrée, ce qui engendre une dépendance stratégique pour les pays cherchant à développer les énergies propres, l'industrie de la défense et l'électronique de nouvelle génération », a déclaré Ram Ramaseshan, cofondateur et membre du conseil d'administration de Hylenr Technologies.

Les travaux de Hylenr Technologies laissent entrevoir un modèle totalement différent : produire certains éléments par nucléosynthèse artificielle plutôt que de les extraire exclusivement de gisements géologiques.

Cela pourrait ouvrir une nouvelle voie technologique pour l'Inde, vers une souveraineté en matière de matériaux essentiels dans les domaines de la défense, de l'électronique, de la mobilité électrique, des énergies renouvelables, de l'espace et de l'industrie de pointe.

Pour le monde entier, cela soulève la possibilité que l'accès futur à ces éléments stratégiques puisse dépendre non seulement des lieux où ils se trouvent à l'état naturel, mais aussi de notre capacité à modifier les environnements nucléaires au sein des matériaux afin de les créer.

« Ce qui rend cette découverte passionnante, c'est la possibilité de réunir l'énergie de fusion nucléaire et les matériaux à base de terres rares au sein d'une même plateforme nucléaire conçue à cet effet », a déclaré Siddhartha Durairajan, cofondateur et membre du conseil d'administration de Hylenr Technologies.

« Depuis des milliers d'années, l'accès à un élément dépend de la concentration que la nature lui a donnée à un endroit donné de la croûte terrestre. Nous œuvrons à la construction d'un avenir très différent, dans lequel nous pourrons concevoir l'environnement matériel nécessaire à la création d'éléments choisis. »

Relations avec les investisseurs

Share this article

GRAND RAPIDS, Mich., Sept. 9, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations", or "the company") (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it has entered into an exclusive collaboration with ALM Ortho, Inc. ("ALM Ortho"), a leader in additive manufacturing of titanium orthopedic implants, to introduce a bespoke implant for the treatment of severe shoulder deformity and other highly complex revision cases, circumstances for which no adequate solution currently exists.

Informed by patient imaging data, ALM Ortho's implants are designed on a case-by-case basis, personalized to individual patient needs and anatomy, and delivered to surgical teams for implantation. Under the collaboration agreement, Shoulder Innovations holds exclusive rights for upper extremity applications of ALM Ortho's solutions in the United States. Shoulder Innovations will leverage its existing ecosystem, including its established surgeon relationships and sales organization, to identify appropriate cases and connect surgeons and facilities with the ALM Ortho solution, while ALM Ortho will design, manufacture, and deliver these devices to surgeons.

"This collaboration bolsters our broader array of offerings to the shoulder surgical care market and importantly helps address a real unmet need for patients and surgeons facing these complex cases," said Rob Ball, CEO of Shoulder Innovations. "We look forward to working with ALM Ortho with this new capability in the marketplace, which we expect will drive improved patient outcomes and yield strategic advantages for SI as our commercial engine continues to grow."

Specific financial terms of the agreement are confidential.

About Shoulder Innovations

Shoulder Innovations is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, with a current offering of advanced implant systems for shoulder arthroplasty. These systems are a core element of Shoulder Innovations' ecosystem, which is designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain. Shoulder Innovations' ecosystem is also comprised of enabling technologies, efficient instrument systems, specialized support and surgeon-to-surgeon collaboration. Together, these elements seek to address the long-standing clinical and operational challenges in the shoulder surgical care market by delivering predictable outcomes, procedural simplicity, and efficiency across all sites of care.

About ALM Ortho, Inc.

ALM Ortho is focused on developing and delivering innovative orthopedic implants for the spine, total joints, oncology, CMF, and extremities. ALM Ortho is leveraging advanced software tools to build an innovative platform to deliver more patient-matched device solutions to market while also holding steady with the more traditional serial implant manufacturing and sales model.

Contact

Brian Johnston or Sam Bentzinger

Gilmartin Group LLC

[email protected]

SOURCE Shoulder Innovations

Share this article

Cohen & Steers Announces Preliminary Assets Under Management and Net Flows for August 2026

NEW YORK, Sept. 9, 2026 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today reported preliminary assets under management of $101.0 billion at August 31, 2026, a decrease of $1.5 billion from assets under management of $102.5 billion at July 31, 2026. The decrease was due to market depreciation of $1.9 billion and distributions of $155 million, partially offset by net inflows of $528 million.

About Cohen & Steers. Cohen & Steers is a leading global investment manager specializing in real assets and alternative income, including listed and private real estate, preferred securities, infrastructure, resource equities, commodities, as well as multi-strategy solutions. Founded in 1986, the firm is headquartered in New York City, with offices in London, Dublin, Hong Kong, Tokyo and Singapore.

SOURCE Cohen & Steers, Inc.

Share this article

NEW YORK, Sept. 9, 2026 /PRNewswire/ --

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Avis Budget Group, Inc. (NASDAQ: CAR), including those who bought Avis common stock to cover a short position, between February 20, 2025 and April 21, 2026, inclusive (the "Class Period"), of the important September 29, 2026 lead plaintiff deadline.

So what: If you purchased Avis securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the Avis class action, go to https://rosenlegal.com/cases/avis-budget-group-inc-2026/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 29, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the lawsuit, defendants Pentwater Capital Management LP and Matthew Halbower (Pentwater's CEO, CIO and Founder) orchestrated a scheme to manipulate the market for Avis securities. Taking advantage of Pentwater's position as one of Avis's largest shareholders, holding a total economic interest of approximately 51% of Avis through stocks and cash-settled swaps as of March 2026, defendants' aggressive purchasing of Avis stock during the Class Period triggered unusual volatility and a short squeeze in the market for Avis securities – i.e., a rapid surge in Avis's stock price caused by short sellers buying back shares to cut their losses, thereby fueling further price spikes – all of which served to greatly increase the value of Pentwater's holdings of Avis stock.

To join the Avis class action, go to https://rosenlegal.com/cases/avis-budget-group-inc-2026/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

     Laurence Rosen, Esq.

     Phillip Kim, Esq.

     The Rosen Law Firm, P.A.

     275 Madison Avenue, 40th Floor

     New York, NY 10016

     Tel: (212) 686-1060

     Toll Free: (866) 767-3653

     Fax: (212) 202-3827

     [email protected]

     www.rosenlegal.com

SOURCE THE ROSEN LAW FIRM, P. A.

Share this article

Employee-owned Huntsville contractor continues long-standing support of the Missile and Space Intelligence Center.

HUNTSVILLE, Ala., Sept. 9, 2026 /PRNewswire/ -- Radiance Technologies, a 100% employee-owned prime contractor, announced today that it has been selected as an awardee on the $14 billion Contract Operations for Missile Evaluation and Testing (COMET) Multi-Award Task Order Contract (MATOC) supporting the Missile and Space Intelligence Center (MSIC).

"This win belongs to our employee-owners," said Radiance Technologies CEO, Bill Bailey. "They built the technical intelligence expertise that got us here, and now they get to put it to work on a mission that's right in our backyard. We're excited to keep supporting MSIC and the vital work they do for the Warfighter."

Under the contract, Radiance will provide research, development, and sustainment services for new and existing hardware, software, and systems that are foundational to military intelligence upon successful awarded contract.

COMET spans five mission task areas: foundational and technical intelligence analysis, foreign materiel exploitation, information technology operations, modeling and simulation, and business processes. It carries a 10-year period of performance, running from July 21, 2026, through January 1, 2037.

In addition to leading its own team, Radiance holds positions on two other winning COMET teams: one led by SAIC and one through its Radiance Ignite Technologies joint venture.

MSIC, part of the Defense Intelligence Agency, provides policymakers, homeland security and intelligence community organizations, weapons developers, and warfighters with intelligence assessments of foreign weapons systems. This includes. anti-tank guided missiles, ground-based air defense and missile defense systems, short-range and close-range ballistic missiles, and ground-based direct-ascent and directed-energy anti-satellite missile systems.

About Radiance Technologies:

Radiance Technologies is an employee-owned prime contractor founded in 1999 and headquartered in Huntsville, Alabama. Radiance has over 1200 employee-owners across the United States serving the Department of War, the national intelligence community, and other government agencies. From concepts to capabilities, Radiance leads the way in developing customer-focused solutions in the areas of cybersecurity, systems engineering, prototyping, and integration, as well as operational and strategic intelligence, including scientific and technical intelligence. For more information, please visit www.radiancetech.com.

Media Contact:

Julia Parrish

Director, Strategic Branding & Communications

[email protected]

SOURCE Radiance Technologies

Share this article

Vortex returns 30.5 meters at 780.53 g/t silver and 6.1 meters at 21.12 g/t gold

Brimstone extends north with 5.5 meters at 1,345.27 g/t silver

WINNEMUCCA, Nev., Sept. 9, 2026 /PRNewswire/ -- Hycroft Mining Holding Corporation (Nasdaq: HYMC) ("Hycroft" or "the Company") announces additional drill results from the 2025-2026 Exploration Drill Program (the "Drill Program") at the Hycroft Mine, located in Nevada, USA, a Tier-1 mining jurisdiction.

Vortex Drill Highlights:

- H26D-6090: 30.5 meters at 780.53 g/t silver and 0.49 g/t gold

- Including 11.2 meters at 1,664.80 g/t silver and 0.85 g/t gold

- Also including 5.5 meters at 2,249.39 g/t silver and 1.01 g/t gold

- H26D-6166: 20.0 meters at 460.82 g/t silver and 0.32 g/t gold 

- Including 6.1 meters at 952.37 g/t silver and 0.54 g/t gold

- Also including 1.6 meters at 2,650.00 g/t silver and 0.91 g/t gold

- H26D-6172: 6.1 meters at 28.65 g/t silver and 21.12 g/t gold

- Including 1.5 meters at 49.40 g/t silver and 43.00 g/t gold

Brimstone Drill Highlights:

- H26D-6167A: 5.5 meters at 1,345.27 g/t silver and 0.56 g/t gold

- Including 1.8 meters at 4,074.00 g/t silver and 1.43 g/t gold

Diane Garrett, Executive Chairman and CEO, commented: "These are some of the strongest results we've seen from the Drill Program. We're not just confirming the high-grade silver system, we're extending it and are consistently intersecting thick, continuous, high-grade mineralization. We have also intersected a high-grade gold interval higher in the known system that we intend to follow up on as we are seeing an increasing number of higher-grade gold intercepts in this area of Vortex. These results continue to confirm our exploration strategy and underpin the potential for a high-grade underground mine. With the system open in all directions and at depth, we see a clear opportunity for continued expansion and growth of these high-grade mineralized systems."

Drill results can be viewed in 3D using VRIFY at the following link:

https://vrify.com/meetings/recordings/9b47dc5c-bbbe-4db2-a4d5-9040ce5763bc

Table 1. Drill Intercept Highlights

Vortex Results

Hole H26D-6090 and H26D-6166 returned 30.5 meters at 780.53 g/t silver and 20.0 meters at 460.82 g/t silver, respectively. Both were drilled offsetting H25D-6070 and H25D-6072 and connect that 2025 step-out drilling to the main Vortex trend. Mineralization remains open to the west, down dip along the Central and Albert faults, currently interpreted as two of the more productive feeder structures at Vortex, and to the north and south.

Holes H26D-6172 tested the northern flank of Vortex and hit four separate silver intervals down hole in the footwall of the Break fault: 23.0 meters at 137.23 g/t silver and 0.69 g/t gold, 12.3 meters at 112.91 g/t silver and 0.25 g/t gold, 21.7 meters at 121.94 g/t silver and 0.89 g/t gold, and 11.1 meters at 177.97 g/t silver and 0.62 g/t gold, demonstrating the vertical continuity and extent of Vortex in this area.

H26D-6173, drilled down dip to the west of H26D-6172, returned 7.4 meters at 134.13 g/t silver, including 2.7 meters at 284.05 g/t silver, and 6.1 meters at 33.99 g/t silver and 2.63 g/t gold. These results further extend the high-grade continuity along the northern flank of the system.

Hole H26D-6172 also returned a high-grade gold interval higher in the hole, 6.1 meters at 21.12 g/t gold, including 1.5 meters at 43.00 g/t gold. This intercept lies higher in the Vortex high-grade silver system. With an increasing number of higher-grade gold intercepts in this area, the Company is planning follow-up drilling to determine the orientation and extent of this mineralization and whether it represents a separate high-grade gold system.

Brimstone Results

At Brimstone, the strategy is to develop the high-grade stockwork vein zone, test the controls on mineralization to the north, south and down dip, and identify and develop high-grade opportunities. Hole H26D-6167A was designed to test and extend high-grade mineralization to the north. The hole encountered a 30-meter silicified breccia that hosted high-grade silver, intersecting 5.5 meters at 1,345.27 g/t silver, including an impressive 1.8 meters at 4,074.00 g/t silver. This intercept opens up additional target opportunities and follow-up drilling is being planned.

Qualified Person

The Company's Qualified Person for exploration is Alex Davidson, Vice President, Exploration, who has reviewed and approved the scientific and technical information contained in this news release.

About Hycroft Mining Holding Corporation

Hycroft Mining Holding Corporation is a US-based gold and silver company exploring and developing the Hycroft Mine, among the world's largest precious metals deposits, located in Nevada, a Tier-1 mining jurisdiction. With a long history of heap leach operations, Hycroft is advancing to the next phase of operations for processing sulfide mineralization. In addition, Hycroft is engaged in a robust exploration drill program (2025-2026 Exploration Drill Program) to expand and advance the two new high-grade silver systems Brimstone and Vortex. These discoveries represent a significant value driver for the Hycroft Mine.

For Further Information

Investor Relations:

E: [email protected]

P: 775-245-0564

Media:

E: [email protected]

P: 775-245-0564

Cautionary Note Regarding Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, included in this press release and in public statements by our officers or representatives that address activities, events or developments that we expect or anticipate will or may occur in the future are forward-looking statements. These include, but are not limited to, statements regarding future business strategy, plans and goals, competitive strengths, the advancement and development of the Hycroft Mine, the results and implications of metallurgical analysis and test work, and the expansion and growth of our business.

Forward-looking statements are often identified by future or conditional words such as "estimate," "plan," "anticipate," "expect," "intend," "believe," "target," "budget," "may," "can," "will," "would," "could," "should," "seeks," "scheduled to" and similar words or expressions but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are based on current expectations, estimates and projections that involve a number of risks and uncertainties, which could cause actual results to differ materially from those reflected in the statements. The risks include, but are not limited to: (i) risks related to changes in our operations at the Hycroft Mine, including risks associated with the cessation of mining operations at the Hycroft Mine; uncertainties concerning estimates of mineral resources; risks related to the lack of a completed feasibility study; risks related to metallurgical test work and process development; and risks related to our ability to re-establish commercially feasible mining and processing operations; and (ii) industry-related risks, including fluctuations in the price of gold and silver; the commercial success of, and risks related to, our exploration and development activities; uncertainties and risks related to our reliance on contractors and consultants; and the availability and cost of equipment, supplies, energy or reagents.

Any exploration target described in this press release does not represent, and should not be construed to be, an estimate of a mineral resource or mineral reserve. Ranges of potential tonnage and grade (or quality) of an exploration target are conceptual in nature; there has been insufficient exploration of the relevant property or properties to estimate a mineral resource; and it is uncertain if further exploration will result in the estimation of a mineral resource.

These and other risks may cause actual results to differ materially from those expressed or implied by the forward-looking statements, and the occurrence of one or more of these events or circumstances, alone or in combination with others, may have a material adverse effect on our business, cash flows, financial condition and results of operations. Please see the "Risk Factors" outlined in our Annual Report on Form 10-K for the year ended December 31, 2025, and in other reports filed with the SEC, for more information about these and other risks.

Given these risks and uncertainties, you are cautioned not to place undue reliance on these forward-looking statements. Although we have attempted to identify important factors that could cause actual results to differ materially from those described in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. Although these forward-looking statements are based on assumptions that we believe are reasonable when made, forward-looking statements are not guarantees of future performance and actual results, performance or achievements may differ materially from those made in or suggested by the forward-looking statements in this press release.

Any forward-looking statements made in this press release speak only as of the date of this press release. We undertake no obligation to update these forward-looking statements or to publicly announce the results of any revisions to any of those statements to reflect future events or developments, except as required by law.

SOURCE Hycroft Mining Holding Corporation

Share this article

Key Takeaways:

- Fazal F. Merchant joined the AT&T Board, effective Sept. 8.

- Merchant will serve on the Audit Committee and the Corporate Development and Finance Committee.

DALLAS, Sept. 9, 2026 /PRNewswire/ -- AT&T (NYSE:T) elected Fazal F. Merchant to its board of directors, effective Sept. 8. He will serve on the Audit Committee and the Corporate Development and Finance Committee.

Merchant most recently served as President and Chief Financial Officer of Wiz, Inc. – a leading cloud and AI security company. He previously was Co-Chief Executive Officer, Chief Operating Officer and Chief Financial Officer of Tanium Inc.

"Fazal is a great addition to our board, bringing deep expertise across corporate development, finance and technology," said John Stankey, AT&T Chairman and CEO. "Fazal's experience scaling high-growth businesses and helping companies navigate periods of transformation will be invaluable as we continue to evolve, invest for growth, and create long-term value for our shareholders."

Merchant previously held senior leadership roles at DreamWorks Animation and DIRECTV, including Chief Financial Officer of DIRECTV Latin America. During his tenure at both companies, he oversaw major strategic transactions. Earlier, he worked in investment banking at Barclays Capital and the Royal Bank of Scotland. He began his career at Ford Motor Company.

Merchant serves on the board of Warner Bros. Discovery and previously served on the boards of Ariel Investments, Ryman Hospitality Properties, Inc. and Meritor, Inc. He also spent several years serving as a senior advisor to Sixth Street Partners.

Merchant holds a Bachelor of Business Administration from The University of Texas at Austin and an MBA from Indiana University.

To automatically receive AT&T financial news by email, please subscribe to email alerts.

About AT&T

We help more than 100 million U.S. families, friends and neighbors, plus nearly 2.5 million businesses, connect to greater possibility. From the first phone call 150 years ago to our 5G wireless and multi-gig internet offerings today, we @ATT innovate to improve lives. For more information about AT&T Inc. (NYSE:T), please visit us at about.att.com. Investors can learn more at investors.att.com.

© 2026 AT&T Intellectual Property. All rights reserved. AT&T and the Globe logo are registered trademarks of AT&T Intellectual Property.

SOURCE AT&T

Share this article

DecisionDx-SCC shows enhanced performance with the integration of select clinicopathologic risk factors, providing a more precise result to support risk-aligned patient management

DecisionDx-SCC's Class 1A (low risk) result demonstrated a 97.3% negative predictive value, supporting confidence in de-escalation decisions, while its Class 2B (highest risk) result identified patients most likely to benefit from adjuvant radiation therapy

FRIENDSWOOD, Texas, Sept. 9, 2026 /PRNewswire/ -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced the publication of a multi-center study in the Journal of the American Academy of Dermatology (JAAD) validating the integrated DecisionDx-SCC test result (i40-GEP) for patients with high-risk cutaneous squamous cell carcinoma (SCC).1

DecisionDx-SCC analyzes 40 genes to provide results related to prognosis and response to adjuvant radiation therapy (ART) based on an individual patient's tumor biology. The enhanced algorithm integrates the molecular data with five clinicopathologic risk factors (immunosuppression, tumor diameter, histological differentiation, perineural invasion and anatomic site) using optimized nested predictive models. This integrated approach provides a comprehensive assessment of metastatic risk, local recurrence risk and likelihood of benefit from ART. The study published in JAAD showed that the test results can shift or stratify patients across clinically actionable risk thresholds, supporting risk-aligned decisions regarding patient follow-up, surveillance imaging, multidisciplinary referral and ART.

"Managing high-risk SCC patients can be challenging because clinicopathologic staging isn't always precise enough to confidently tailor patients' treatment intensity to their individual level of risk," said lead study author Désirée Ratner, M.D., board-certified dermatologist and Mohs micrographic surgeon, and clinical professor of dermatology at NYU Grossman School of Medicine in New York. "The ability to more precisely distinguish which patients require less intensive management from those who would benefit from additional treatment can help reduce uncertainty for both patients and physicians. This study showed that the DecisionDx-SCC integrated test result, which evaluates patients' tumor biology in combination with their clinicopathologic risk factors, can provide improved, clinically actionable information to support informed discussions about the most appropriate, risk aligned management approach."

The study, titled "Validation of the integrated 40-gene expression profile (i40-GEP) which provides prognostic and adjuvant radiation benefit for high-risk cutaneous squamous cell carcinoma," evaluated the enhanced DecisionDx-SCC algorithm in an independent validation cohort of 572 patients with high-risk SCC.

Key study findings include:

- DecisionDx-SCC significantly stratified patients by metastatic and local recurrence risk (p0.0001 for both). In multivariable analysis, the test results provided significant predictive information beyond individual clinicopathologic risk factors for both outcomes.

- Nearly half of patients in the cohort (44.6%) were classified by the i40-GEP test as Class 1A (low risk). This result demonstrated a 97.3% negative predictive value (NPV) and may support greater confidence when considering de-escalation of care in low-risk patients.

- The refined algorithm classified 12.9% of patients as Class 2B (highest risk). These patients had a three-year metastasis-free survival rate of 66.2%, compared with 97.3% for patients with Class 1A (low risk) test results. In multivariable analysis, Class 2B patients were 10.7 times more likely to develop metastasis than Class 1A patients (p0.001), demonstrating strong separation between the test's lowest- and highest-risk results.

- In addition, the Class 2B result identified patients with a high likelihood of benefitting from ART. Patients with Class 2B test results who were treated with ART had an approximately 50% lower median metastatic progression rate at five years than those who did not receive ART. Class 2B ART-treated patients also showed significantly delayed disease progression with decreased acceleration of events compared to Class 2B patients who did not receive ART (p0.01). No significant difference was observed between ART-treated and untreated patients with Class 2A (high risk) test results.

- DecisionDx-SCC demonstrated greater accuracy in predicting metastatic risk than National Comprehensive Cancer Network (NCCN) risk groups and Brigham and Women's Hospital (BWH) staging.

"Continuous innovation at Castle means building on well-established tests as evidence and clinical needs evolve," said Rebecca Critchley-Thorne, Ph.D., vice president, research and development, at Castle Biosciences. "By preserving DecisionDx-SCC's established 40-gene foundation while refining its algorithm to integrate clinicopathologic factors, we can provide more precise, clinically actionable information while maintaining the test's core molecular profile. The study published in JAAD validates these refinements designed to increase confidence in lower-risk results, provide greater clarity for intermediate-risk patients and identify the highest-risk patients most likely to benefit from ART."

About DecisionDx-SCC

DecisionDx-SCC is a gene expression profile (GEP) test that integrates tumor biology and key clinicopathologic risk factors to deliver a refined, personalized risk assessment for patients with cutaneous squamous cell carcinoma (SCC) and one or more high-risk factors. The test provides a patient's individual risk of metastasis and local recurrence, as well as likelihood of benefit from adjuvant radiation therapy (ART). This clinically actionable information is designed to help guide risk-aligned management decisions, including surveillance, imaging, multidisciplinary consultation and consideration of ART.

DecisionDx-SCC has been clinically validated in a multicenter study of patients with localized high-risk cutaneous SCC, in which it was shown to be the strongest predictor of metastasis and local recurrence compared with individual clinicopathologic risk factors and to outperform traditional risk assessment systems. The study adds to a broader evidence base of 20 peer-reviewed publications supporting the test's clinical performance and role in informing individualized patient management. Learn more at DecisionDx-SCC Overview.

About Castle Biosciences

Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. With a primary focus in dermatologic and gastroenterological disease, we develop personalized, clinically actionable solutions that help improve disease management and patient outcomes.

We put people first—empowering patients and clinicians and informing care decisions through rigorous science and advanced molecular tests that support more confident treatment planning. To learn more, visit www.CastleBiosciences.com and connect with us on LinkedIn, Instagram, Facebook and X.

DecisionDx-Melanoma, DecisionDx-CMSeq, i31-SLNB, i31-ROR, DecisionDx-SCC, MyPath Melanoma, AdvanceAD-Tx, TissueCypher, Esopredict, DecisionDx-UM, DecisionDx-PRAME and DecisionDx-UMSeq are trademarks of Castle Biosciences, Inc.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to the "safe harbor" created by those sections. These forward-looking statements include, but are not limited to, statements concerning the ability of DecisionDx-SCC to: (i) improve risk stratification and strengthen treatment guidance; (ii) provide more precise and actionable information; (iii) reduce uncertainty in the care journey and support greater confidence when considering de-escalation of management for lower-risk patients; (iv) provide clarity for intermediate-risk patients; (v) identify highest-risk patients who are most likely to benefit from ART; and (vi) inform personalized, risk-aligned decisions involving follow-up, surveillance imaging, multidisciplinary consultation and ART. The words "can," "designed," "may" and similar expressions are intended to identify forward intentions or expectations, and you should not place undue reliance on our forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements that we make. These forward-looking statements involve risks and uncertainties that could cause actual results to differ from the forward-looking statements, including, without limitation: subsequent study or trial results and findings may contradict earlier study or trial results and findings or may not support the results obtained in these studies; actual application of our tests may not provide the aforementioned benefits to certain patients; and the risks set forth under the heading "Risk Factors" in our Annual Report on Form 10-K for the year ended Dec. 31, 2025, our subsequent Quarterly Reports on Form 10-Q and our other filings with the Securities and Exchange Commission. The forward-looking statements are applicable only as of the date on which they are made, and we do not assume any obligation to update them, except as may be required by law.

- Ratner D, Singh G, Rizzo JM, et al. Validation of the integrated 40-gene expression profile (i40-GEP) which provides prognostic and adjuvant radiation benefit for high-risk cutaneous squamous cell carcinoma. J Am Acad Dermatol. Published online August 24, 2026. Accessed August 25, 2026. https://www.jaad.

Hylenr Technologies entdeckt Spuren von Seltenen Erden und eröffnet durch Kernfusion einen neuen technologischen Weg

HYDERABAD, Indien, 9. September 2026 /PRNewswire/ -- Das indische Deep-Tech-Unternehmen Hylenr Technologies hat Hinweise auf die Bildung von Elementen, darunter Seltenerdmetalle, innerhalb künstlich geschaffener Gitterstrukturen gemeldet – und eröffnet damit einen radikal neuen Weg zur Nukleosynthese und zur Herstellung strategischer Werkstoffe.

Die Ergebnisse sind Teil der Arbeit von Hylenr Technologies in den letzten mehr als zehn Jahren auf dem Gebiet der Kernfusionstechnologie auf der Grundlage der Gitter-Einschluss-Fusion (Lattice confinement fusion). Dabei wurden die Ergebnisse durch die Zusammenarbeit des Unternehmens mit führenden internationalen Forschungseinrichtungen validiert.

Ein Teil dieser Arbeit mit dem Titel Nuclear Signatures in a Hydrogen-Loaded Ni–Pd Lattice Confinement System wurde Anfang dieses Monats auf der 27th International Conference on Condensed Matter Nuclear Science (ICCF-27) in Niagara Falls, Kanada, vorgestellt.

Von der Kernenergie zur Nukleosynthese

Die Nukleosynthese ist der Prozess, bei dem Atomkerne umgewandelt werden, um verschiedene Elemente zu erzeugen.

In der Natur findet dies im Inneren von Sternen, Supernovae und anderen extremen astrophysikalischen Umgebungen statt, wo enorme Temperaturen, Drücke und Energiedichten Kernreaktionen antreiben.

Auf der Erde erfordert die Erzeugung oder Umwandlung von Elementen durch nukleare Prozesse in der Regel großtechnische Kernreaktoren, Teilchenbeschleuniger oder hochenergetische Versuchseinrichtungen.

Die Ergebnisse von Hylenr Technologies zeigen einen grundlegend anderen Weg für Kernprozesse und Nukleosynthese in künstlich hergestellten Feststoffen auf, In mit Wasserstoff beladenen Metallgittern schaffen Wechselwirkungen zwischen Wasserstoff, Gitterfehlern, Leerstellen und der lokalen elektronischen Umgebung stark begrenzte Bedingungen, die Kernprozesse innerhalb des Materials selbst ermöglichen.

Dies verlagert die Vorstellung von der Elementbildung von riesigen Hochenergiesystemen hin zu kompakter, künstlich erzeugter Kernenergie.

Signaturen von 32 Elementen nachgewiesen

Im Rahmen einer etwa zweijährigen Materialanalyse hat Hylenr Technologies in Proben aus dem Betriebsbetrieb Signaturen nachgewiesen, die 32 Elementen entsprechen, darunter leichte Elemente, schwere Elemente sowie Edelgase wie Helium, Neon und Argon. Darüber hinaus wurden strategisch wichtige Seltenerdelemente wie Yttrium sowie Aktinide wie Uran nachgewiesen. Die Signaturen werden im Vergleich zur Basis-Charakterisierung derselben Katalysatormaterialprobe vor dem Betrieb, die als Kontrolle dient, ausgewiesen, und jede wird durch mehr als eine der folgenden unabhängigen Techniken bestätigt.

Die Beobachtungen wurden mithilfe mehrerer unabhängiger Analyseverfahren untersucht, darunter:

- Energiedispersive Röntgenspektroskopie (EDX)

- Röntgen-Photoelektronenspektroskopie (XPS)

- Induktiv gekoppelte Plasma-Emissionsspektroskopie (ICP-OES)

- Welllängendispersive Röntgenspektroskopie (WDX)

- Restgasanalyse (RGA)

Hergestellt, nicht abgebaut

Seltenerdelemente stehen im Mittelpunkt vieler der weltweit strategisch wichtigsten Technologien.

Sie sind unverzichtbar für Permanentmagnete, Elektrofahrzeuge, Robotik, Windkraftanlagen, Elektronik, Luft- und Raumfahrtsysteme, Verteidigungsplattformen und fortschrittliche Fertigung.

„Dennoch ist ihre globale Lieferkette nach wie vor stark konzentriert, was zu einer strategischen Abhängigkeit für Länder führt, die den Ausbau von sauberer Energie, der Rüstungsindustrie und der Elektronik der nächsten Generation anstreben", erklärte Ram Ramaseshan, Mitbegründer und Vorstandsmitglied von Hylenr Technologies.

Die Arbeit von Hylenr Technologies weist auf ein völlig anderes Modell hin: ausgewählte Elemente durch künstliche Nukleosynthese herzustellen, anstatt sie ausschließlich aus geologischen Lagerstätten zu gewinnen.

Für Indien könnte dies einen neuen technologischen Weg zur Souveränität bei kritischen Materialien in den Bereichen Verteidigung, Elektronik, Elektromobilität, erneuerbare Energien, Raumfahrt und fortschrittliche Fertigung eröffnen.

Für die Welt eröffnet dies die Möglichkeit, dass der künftige Zugang zu strategischen Elementen nicht nur von deren natürlichen Vorkommen abhängt, sondern auch von unserer Fähigkeit, die Kernumgebungen innerhalb von Materialien so zu gestalten, dass diese Elemente entstehen.

„Was diese Entdeckung so spannend macht, ist die Möglichkeit, Kernfusions-energie und Seltenerdmaterialien auf einer einzigen technischen Nuklearplattform zusammenzuführen ", sagte Siddhartha Durairajan, Mitbegründer und Vorstandsmitglied von Hylenr Technologies.

„Seit Jahrtausenden hängt der Zugang zu einem Element davon ab, ob die Natur es irgendwo in der Erdkruste angereichert hat. Wir arbeiten auf eine ganz andere Zukunft hin – eine, in der wir die materielle Umgebung technisch gestalten können, die zur Erzeugung ausgewählter Elemente erforderlich ist."

Investorenbeziehungen

Share this article